Effect of ascorbic acid supplementation on certain oxidative stress parameters in the post reperfusion patients of myocardial infarction

Molecular and Cellular Biochemistry

Volumn 290, Issue 1-2, 2006, Pages 153-158

  Bhakuni, Pushpa ^a   Chandra, M ^b   Misra, M K ^a  

^a UNIVERSITY OF LUCKNOW   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Ascorbicacid; Freeradical scavengers; Myocardial infarction; Oxidativestress; Thiols

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ASCORBIC ACID; MALONALDEHYDE; SCAVENGER; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; BLOOD CLOT LYSIS; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; REPERFUSION INJURY; VITAMIN SUPPLEMENTATION;

ASCORBIC ACID; HUMANS; MALONDIALDEHYDE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REPERFUSION; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

EID: 33749168029     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9182-y     Document Type: Article

References (39)

1. Frei B, England L, Ames BN: Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 86: 6377-6381, 1989
2. Frei T, Stocker R, England L, Ames BN: Ascorbate: the most effective antioxidant in human blood plasma. Adv Exp Med Biol 264: 155-163, 1990
3. Weber P, Bendich A, Schalch W: Vit C and human health-a review of recent data related to human requirements. Int J Vitam Nutr Res 66: 19-30, 1996
4. Enstrom JE: Vit C in prospective epidemiological studies. In: L Packer, J Fuchs (eds) Vitamin C in health and disease. New York: Marcel Decker Inc. 381-398, 1997
5. Gey KF: Vitamins E plus C and interacting conutrients required for optimal health. Biofactors 7: 113-174, 1998
6. Bordia AK: The effect of Vitamin C on blood lipids, Fibrinolytic activity and platelet adhesiveness in patients with coronary artery disease. Atherosclerosis 35: 181-187, 1980
7. Bordia A, Verma SK: Effect of vitamin C on platelet adhesiveness and platelet aggregation in coronary artery disease patients. Clin Cardiol 8: 552-554, 1985
8. HalliAell B: Vitamin C: antioxidant or pro-oxidant in Vivo. Free Radic Res 25: 439-454, 1996
9. Packer L: Vitamin C and redox cycling antioxidants. In: L Packer, J Fuchs, (eds). Vitamin C in health and disease. New York: Marcel Dekker Inc 95-121, 1997
10. Bowry VW, Mohr D, Cleary J, Stocker R: Prevention of tocopherol mediated peroxidation in ubiquinol-10-free human low density lipoprotein. J Biol Chem 270: 5756-5763, 1995
11. Klenner FR: Observations on the dose and observations of ascorbic acid when employed beyond the range of a vitamin in human pathology. J App Nutr 23: 61-88, 1971
12. CathcTrt RF: Vitamin C: titrating to bowel tolerance, an ascorbemia and acute induced scurvy. Medical Hypothesis 7: 1359-1376, 1981
13. Tsao CS: An overview of ascorbic acid chemistry and biochemistry. In: Packer L, Fuchs J, (eds). Vitamin C in health and Disease. New York: Marcel Dekker Inc. 25-58, 1997
14. McCord JM: Oxygen free radicals in post ischemic tissue injury. N Engl J Med 312: 159-163, 1985
15. Halliwell B: Oxygen free radicals and metal ions: Potentail antioxidant intervention strategies. In Cress CE (moderator): Oxygen free radicals and human disease. Ann Int Med 107: 526-545, 1987
16. Halliwell B, Gutterridge GMC, Cross CE: Free radicals, antioxidants and human disease: Where are we now? J Lab Clin Invest 119: 589-620, 1992
17. Slater TF, Cheesman KH, Davies MJ, Proudfoot K, Xin W: Free radical mechanisms in relation to tissue injury. Proc Nutr Soc 46: 1-12, 1987
18. Warso MA, Lands EM: Presence of lipid hydroperoxide in human blood plasma. J Clin Invest 75: 667-671, 1985
19. Frei B, Stocker R, Ames BN: Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 85: 9748-9752, 1988
20. Levy Y, Ben-Amotz A, Aviram M: Effect of dietry supplemention of different β-carotene isomers on lipoprotein oxidative modification. J Nutr Med 5: 13-22, 1995
21. Goldhaber J, Weiss JN: Oxygen free radicals and cardiac reperfusion abnormalities. Hypertension 20: 118-127, 1992
22. Ambroso G, Chiarello M: MMocardial reperfusion injury: mechanisms and management-a review. Am J Med 91: 86-88, 1991
23. Ferrari R, Ceconi C, Curello S, Cargnoni A, De Guili F, Visioli O: Occurrence of oxidative stress during myocardial reperfusion. Mol Cell Biochem 111: 61-69, 1992
24. Luchesi BR: Myocardial Ischemia-reperfusion and free radical injury. Am J Cardiol 65: 141-231, 1990.
25. Misra HP, Fridovich I: The role of superoxide anion in the auto oxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247: 3170-3175, 1972
26. Roussos GG: Xanthine oxidase from bovine small intestine. Meth Enzymol 12: 5-16, 1967
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RG: Protein measurement with Folin phenol reagent. J Biol Chem 193: 265-275, 1951
28. Hu M: Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 233: 380-382, 1994
29. Ohkawa H, Oshishi N, Yagi K: Assay of lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358, 1979
30. Maxwell SRJ, Lip GYH. Reperfusion injury: A review of the pathophysiology, clinical manifestation and therapeutic options. Int J Cardiol 58: 95-117, 1997
31. Zweir JL, Flaherty JT, Weisfeldt ML: Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 84: 1404-1407, 1987
32. Bolli R: Oxygen-derived free radicals and myocardial reperfusion injury: an overview. Cardiovasc Drug Ther 5: 249-268, 1991
33. Bhakuni P, Chandra M, Misra MK: Levels of free radicals scavengers and antioxidants in post-reperfused patients of myocardial infarction. Current Sci 89: 168-170, 2005
34. Robert MJD, Young IS, Trouton TG, Trimble ER, Khan MM, Webb SW, Wilson CM, Patterson GC, Adgey AA: Transient release of lipid peroxides after coronary artery balloon angioplasty. Lancet 336: 143-145, 1990
35. Coughlan JG, Flitter WD, Holley AE, Norell M, Mitchell AG, Iisley CD, Slater TF: Detection of free radicals and cholesterol hydroperoxide in blood taken from the coronary sinus of man during percutaneous transluminal coronary angioplasty. Free Rad Res Comm 14: 403-413, 1991
36. Davies SW, Ranjadayalan K, Wickens DG, Dormandy TL, Timmis AD: Lipid peroxidation associated with successful thrombolysis. Lancet 335: 741-743, 1990
37. Ekelund UEG, Harrison RW, Shokek O, Thakkar RN, Tunin RS, Senzaki H, Kass DA, Marban E, Hare JM: Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. Circ Res 85: 437-445, 1999
38. Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marban E, Hare JM: Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 104: 2407-2411, 2001
39. Jialal I, Gundy SN: Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J Clin Invest 86: 597-601, 1991